Your body generates biological data every day.
We turn it into decisions to help you feel better
NostraBiome analyses your microbiome, genetic profile, integrates all your lab results and medical history, and builds a plan that adjusts constantly — guided by AI, with direct access to human experts.
Download the NostraBiome mobile app on your smartphone or from the web:
10 years
Cumulated research and studies embedded in our technology.
90%
of IBD patients get into full
sustained remission.
94%
of pediatric patients respond
in less than a month
52%
of oncology patients experienced reduced digestive side effects
What is included with every Panel?
1. A microbiome collection kit
Every healing journey begins with a microbiome collection kit, delivered directly to your home.
2. Complete interpretation
We analyze your microbiome data alongside your existing medical information and any other relevant analyses you share with us.
3. Personalized recommendations
Our technology will create a personalized strategy and tailored recommendations to help optimize your microbiome and enhance the success of your therapy.
Beyond today's standard of personalization
Before your recommendation is generated our technology considers:
Your dynamic microbiome inflammatory signature DMIS.
Your medical history &
health status quo.
The predictive chemical load on your immune system.
Over 400,000 medical papers & clinical references.
Clinical studies
At NostraBiome, we are dedicated to advancing the understanding and treatment of complex medical conditions through rigorous clinical research. Our ongoing and planned studies focus on the pivotal role of the microbiome in diseases such as Inflammatory Bowel Disease (IBD) and cancer.
AI-driven microbiome modulation demonstrates significant improvements across diverse groups of IBD and oncology patients.
We detect the hidden
chemical causes of your disease
Your microbiome is the largest producer of chemical metabolites that interact with your immune and metabolic health.
We detect each patient's dynamic inflammatory microbiome signatures connected with their medical condition. We predict the impact load of the microbiome on the immune system and enhance the effectiveness of existing therapies
The signals we look at
Who we are
We are a health and technology company uniting scientific advancements, artificial intelligence, biology, genetics, and medicine.
Our mission is to harness microbiome insights as a key factor in enhancing therapies for inflammatory bowel disease, cancer, and oral health, significantly improving the efficacy of existing treatments and bringing hope to millions.
Endorsed by industry leaders
Dr. Razvan Curca
Medical Oncology
Board Advisor
President of SNOMR
The National Society for Medical Oncology in Romania.
Dr. Belei Oana
Gastroenterology
Board Advisor
Pediatric Gastroenterologist at Louis Turcanu Emergency Pediatric Hospital, Timisoara.
Camelia Isaic
Corporate Development
Board Advisor
Investor relations, fundraising, grant management, social impact and corporate relations.
We believe advanced personalization and biology modulation will lead to a revolution in immunotherapy
We leverage AI, DNA testing, advanced data profiling, and applied science to accelerate the ability of patients worldwide to complement their therapies.
By doing so, we significantly enhance the likelihood of success for conditions where standard treatments have traditionally offered limited effectiveness, such as IBD, cancer, and autoimmune diseases.
